SEC Expands Pfizer Bribery Inquiries Into China
By Al Barbarino · November 6, 2020, 5:37 PM EST
Pfizer Inc. is cooperating with the U.S. Securities and Exchange Commission following a bribery-related inquiry into the drugmaking giant's China operations, according to the company's third-quarter financial statements....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login